Concepedia

Author

Ou Huang

Ruijin HospitalORCID

Also Known As

Huang, Ou, Huang, Ouwen, Kunwei Shen, O Huang, O P Huang, O. Huang, OU HUANG, Ou Huang, Ou huang, Ouwen Huang

140

Publications

2.5K

Citations

28

H-Index

64

Concepts

All Affiliations

Ruijin HospitalShanghai Jiao Tong UniversityChinese Academy of SciencesShanghai Institute of Materia MedicaFudan University Shanghai Cancer Center
OH

About

Ou Huang is an author at Ruijin Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

781

2

Engineering

1

1

36

3

Health Sciences

1

1

42

4

Public Health

1

1

75

5

Biomedical Engineering

1

1

36

Ou Huang

×

56

Publications

2K

Citations

26

H-Index

YearCitations

PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients

Shenyou Sun, Xiaochun Fei, Yan Mao,

Cancer Immunology Immunotherapy

2014

154

Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy

Ou Huang, Liping Wang, Kunwei Shen,

Breast Cancer Research and Treatment

2007

136

Curcumin Induces Cell Death and Restores Tamoxifen Sensitivity in the Antiestrogen-Resistant Breast Cancer Cell Lines MCF-7/LCC2 and MCF-7/LCC9

Min Jiang, Ou Huang, Xi Zhang,

Molecules

2013

107

A novel long non-coding RNA-ARA: Adriamycin Resistance Associated

Min Jiang, Ou Huang, Zuoquan Xie,

Biochemical Pharmacology

2013

104

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer

Renhong Huang, Han Wang, Jin Hong,

Frontiers in Immunology

2023

98

Increased Adverse Pregnancy Outcomes Associated With Stage 1 Hypertension in a Low-Risk Cohort

Dandan Wu, Ling Gao, Ou Huang,

Hypertension

2020

75

Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer

Xiaosong Chen, Long Sun, Yan Mao,

BMC Cancer

2013

68

Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy

Renhong Huang, Zheng Wang, Jin Hong,

Cell Death and Disease

2023

59

Featured Article: Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells

Ou Huang, Weili Zhang, Qiaoming Zhi,

Experimental Biology and Medicine

2014

58

Prognostic and predictive value of Ki-67 in triple-negative breast cancer

Wei Wang, Jiayi Wu, Peifeng Zhang,

Oncotarget

2016

55

Page 1